1887

Abstract

A murine gammaherpesvirus (MHV-68) containing a deletion of the putative plasmid maintenance protein ORF73 exhibits a severe latency deficit. In this study the ability of an ORF73 deletion mutant (Δ73) to confer protection against subsequent challenge with wild-type virus has been examined. Vaccination studies have shown that Δ73 vaccination reduced latent infection of wild-type challenge virus to a level below the limit of detection. These results indicate that a live-attenuated gammaherpesvirus that cannot persist is an effective vaccine.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.19760-0
2004-03-01
2020-10-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/3/vir850609.html?itemId=/content/journal/jgv/10.1099/vir.0.19760-0&mimeType=html&fmt=ahah

References

  1. Adler H., Messerle M., Wagner M., Koszinowski U. H. 2000; Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J Virol 74:6964–6974
    [Google Scholar]
  2. Ballestas M. E., Chatis P. A., Kaye K. M. 1999; Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284:641–644
    [Google Scholar]
  3. Collins C. M., Medveczky M. M., Lund T., Medveczky P. G. 2002; The terminal repeats and latency-associated nuclear antigen of herpesvirus saimiri are essential for episomal persistence of the viral genome. J Gen Virol 83:2269–2278
    [Google Scholar]
  4. Efstathiou S., Ho Y. M., Minson A. C. 1990; Cloning and molecular characterization of the murine herpesvirus 68 genome. J Gen Virol 71:1355–1364
    [Google Scholar]
  5. Flano E., Kim I. J., Moore J., Woodland D. L., Blackman M. A. 2003; Differential gamma-herpesvirus distribution in distinct anatomical locations and cell subsets during persistent infection in mice. J Immunol 170:3828–3834
    [Google Scholar]
  6. Fowler P., Marques S., Simas J. P., Efstathiou S. 2003; ORF73 of murine herpesvirus-68 is critical for the establishment and maintenance of latency. J Gen Virol 84:3405–3416
    [Google Scholar]
  7. Kim I. J., Flano E., Woodland D. L., Blackman M. A. 2002; Antibody-mediated control of persistent gamma-herpesvirus infection. J Immunol 168:3958–3964
    [Google Scholar]
  8. Liu L., Usherwood E. J., Blackman M. A., Woodland D. L. 1999; T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice. J Virol 73:9849–9857
    [Google Scholar]
  9. Marques S., Efstathiou S., Smith K. G., Haury M., Simas J. P. 2003; Selective gene expression of latent murine gammaherpesvirus 68 in B lymphocytes. J Virol 77:7308–7318
    [Google Scholar]
  10. Moorman N. J., Willer D. O., Speck S. H. 2003; The gammaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency. J Virol 77:10295–10303
    [Google Scholar]
  11. Sangster M. Y., Topham D. J., D'Costa S., Cardin R. D., Marion T. N., Myers L. K., Doherty P. C. 2000; Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus. J Immunol 164:1820–1828
    [Google Scholar]
  12. Schäfer A., Lengenfelder D., Grillhösl C., Wieser C., Fleckenstein B., Ensser A. 2003; The latency-associated nuclear antigen homolog of herpesvirus saimiri inhibits lytic virus replication. J Virol 77:5911–5925
    [Google Scholar]
  13. Stevenson P. G., Doherty P. C. 1998; Kinetic analysis of the specific host response to a murine gammaherpesvirus. J Virol 72:943–949
    [Google Scholar]
  14. Stevenson P. G., Belz G. T., Castrucci M. R., Altman J. D., Doherty P. C. 1999a; A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope. Proc Natl Acad Sci U S A 96:9281–9286
    [Google Scholar]
  15. Stevenson P. G., Cardin R. D., Christensen J. P., Doherty P. C. 1999b; Immunological control of a murine gammaherpesvirus independent of CD8+ T cells. J Gen Virol 80:477–483
    [Google Scholar]
  16. Stewart J. P., Janjua N. J., Pepper S. D., Bennion G., Mackett M., Allen T., Nash A. A., Arrand J. R. 1996; Identification and characterization of murine gammaherpesvirus 68 gp150: a virion membrane glycoprotein. J Virol 70:3528–3535
    [Google Scholar]
  17. Stewart J. P., Usherwood E. J., Ross A., Dyson H., Nash T. 1998; Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J Exp Med 187:1941–1951
    [Google Scholar]
  18. Sunil-Chandra N. P., Efstathiou S., Nash A. A. 1992; Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo . J Gen Virol 73:3275–3279
    [Google Scholar]
  19. Tibbetts S. A., McClellan J. S., Gangappa S., Speck S. H., Virgin H. W. 2003; Effective vaccination against long-term gammaherpesvirus latency. J Virol 77:2522–2529
    [Google Scholar]
  20. Usherwood E. J., Roy D. J., Ward K., Surman S. L., Dutia B. M., Blackman M. A., Stewart J. P., Woodland D. L. 2000; Control of gammaherpesvirus latency by latent antigen-specific CD8(+) T cells. J Exp Med 192:943–952
    [Google Scholar]
  21. Usherwood E. J., Ward K. A., Blackman M. A., Stewart J. P., Woodland D. L. 2001; Latent antigen vaccination in a model gammaherpesvirus infection. J Virol 75:8283–8288
    [Google Scholar]
  22. Virgin H. W., 4th., Latreille P., Wamsley P., Hallsworth K., Weck K. E., Dal Canto A. J., Speck S. H. 1997; Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 71:5894–5904
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.19760-0
Loading
/content/journal/jgv/10.1099/vir.0.19760-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error